Pituitary
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 62.0% | 1.160 | Q2 | 87.3% |
| 2024 | 3.4 | Q2 | 61.7% | 1.086 | Q2 | 86.2% |
| 2023 | 3.3 | Q2 | 56.9% | 1.091 | Q1 | 87.6% |
| 2022 | 3.8 | Q2 | 58.7% | 0.803 | Q2 | 80.6% |
| 2021 | 3.6 | Q3 | 52.5% | 0.877 | Q2 | 83.6% |
| 2020 | — | — | 1.056 | Q2 | 86.5% | |
| 2019 | — | — | 1.182 | Q1 | 88.9% | |
| 2018 | — | — | 1.009 | Q2 | 84.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1386-341X
ISSN
1573-7403
country
UScoverage
1998-2026